The SELECT cardiovascular outcomes trial (N=17,604), published in NEJM 2023 (DOI: 10.1056/NEJMoa2307563), demonstrated a 20% reduction in major adverse cardiovascular events (MACE) -- the composite of cardiovascular death, non-fatal myocardial infarction, and non-fatal stroke -- in overweight or obese adults without diabetes
When metabolism slows down due to deficiency, weight loss efforts may stall
Jamalpoor A, Othman A, Levtchenko EN, Masereeuw R, Janssen MJ (2021) Molecular mechanisms and treatment options of nephropathic cystinosis
Drug combinations often enhance therapeutic effect or cut needed dose, and similar strategies might reduce side effects in reproductive treatments
Detoksifikasyonda, baklk desteinde ve hatta cilt salnda rol oynar
Glutathione 1500mg is intended for laboratory research use only